Wendy Cameron

Wendy Cameron is a declared insider at 2 companies; the most frequent names are Mylan Laboratories Inc and Mylan II B.V. We count 43 filings; the first trade dates from 27 July 2007 and the latest from 29 June 2018.

In open-market terms, that means 3 purchases worth €198k on one side and 7 sales worth €6.9M on the other. The net balance comes to €6.7M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants and 27 option exercises.

Half of the purchases are above €73k and half below.

Most recently, on 3 July 2018, the filings show a share grant worth €53k in Mylan II B.V. The last purchase on record was published on 9 March 2016, which is 3,881 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.